Artificial Pancreas
FILE
A recent NBC29 article noted the FDA’s approval of a new device that will likely improve the lives of those living with Type 1 Diabetes. Gone are the days of pricing one’s finger to check blood sugar levels and manually injecting insulin thanks to a new artificial pancreas. The device is called Control-IQ, and it’s based on research and technology developed at the University of Virginia. Control-IQ monitors blood glucose levels continuously, and automatically delivers insulin when levels rise.
The FDA’s green light comes after a multicenter clinical trial was published in the New England Journal of Medicine that found the Control-IQ to be more effective than existing treatments for type 1 diabetes.
![“Another key [UDI] benefit, because we're calling that product by the same name across the healthcare supply chain… rich and robust data that we can access around supply consumption and utilization rates. One of the buzz terms we've heard during the COVID-19 crisis was what's my burn rate? How fast am I going through gowns, masks, gloves?” – Mike Schiller, Senior Director at AHRMM](https://img.healthcarepackaging.com/files/base/pmmi/all/image/2020/08/UDI.5f4d326e41d53.png?auto=format&fit=crop&h=146&w=340)
